Media Resources
About KFF
KFF is the leading health policy organization in the U.S., bringing together substantial capabilities in policy research, polling, and journalism to meet the need for a trusted, independent source of information on national health issues—one with the scope and reach to be a counterweight to health care’s vested interests and a voice for people. Learn more about KFF
Media Contacts
Polling, health reform, health costs, KFF institutional
Craig Palosky
Senior Director of Communications
(202) 347-5270
cpalosky@kff.org
Women’s health policy, global health policy, COVID-19, HIV, LGBTQ+
Mikhaila Richards
Communications Officer
(202) 347-5270
mrichards@kff.org
Medicare, racial equity and health policy, mental health
Chris Lee
Senior Communications Officer
(202) 654-1403
clee@kff.org
Medicaid, the uninsured, KFF Health News
Tammie Smith
Communications Officer
(202) 347-5270
tsmith@kff.org
How to Cite Us
- KFF should be cited as a nonprofit health policy research, polling, and news organization. More about how to cite us.
- KFF encourages news outlets, legislative bodies, academic institutions, and others to link to or reprint our content. More about reprints and permissions.
- KFF logos may only be used to identify our research, polling, journalism, and other work. Request permission to use our logo by emailing logorequests@kff.org.
News Releases
-
Marketplace Insurers are Proposing a 6% Average Premium Hike for 2024 and Pointing to Inflation as a Key Driver of Costs
ACA Marketplace insurers are requesting a median premium increase of 6% for 2024, according to a new KFF analysis of the preliminary rate filings. Insurers’ proposed rate changes – most of which fall between 2% and 10% – may change during the review process. … more
-
Poll: Nearly Half of Adults Would Be Interested in Prescription Weight-Loss Drugs, But Enthusiasm Fades Based on Lack of Coverage and Risk of Regaining Weight
Nearly half (45%) of the public are at least somewhat interested in taking a prescription weight-loss drug, including many who say they only want to lose a little weight, though many people lose interest when presented with potential financial and medical drawbacks, the latest KFF Health Tracking Poll reveals. … more
-
New KFF Health News Podcast Explores How the Eradication of Smallpox in India Informs Public Health Ambitions and Challenges in 2023
KFF Health News today launched a new limited-series podcast, “Epidemic: Eradicating Smallpox,” with host Dr. Céline Gounder, senior fellow and editor-at-large for public health at KFF Health News. The eight-episode podcast takes listeners on a journey to South Asia, the site of the last days of variola major smallpox. … more
-
U.S. Has the Highest Rate of Gun Deaths for Children and Teens Among Peer Countries
Firearms were responsible for 20 percent of all child and teen deaths in the U.S. for both 2020 and 2021, compared to an average of less than 2 percent in similarly large and wealthy nations, according to a new KFF analysis. … more
-
One Year After the Launch of 988, the National Suicide and Crisis Hotline Has Received Nearly 5 Million Combined Calls, Texts, and Chats
Since its launch in July 2022, the 988 national suicide and crisis hotline has received about 4 million contacts, a 33 percent increase from the year before, according to a new KFF analysis of publicly available data through May 2023. The contacts include more than 2. … more
-
In 2022, Donor Governments Spent US$8.2 billion on Efforts to Fight HIV/AIDS Globally, Returning to 2020 Funding Levels and Still Below the High-water Mark of Almost a Decade Ago
A new report from KFF and The Joint United Nations Programme on HIV/AIDS (UNAIDS) reveals that donor governments disbursed US$8.2 billion in 2022 to combat HIV in low- and middle-income countries, returning to 2020 funding levels and still below the high-water mark of $8.6 billion in 2014. … more
-
10 Prescription Drugs Accounted for $48 Billion in Medicare Part D Spending in 2021, or More Than One-Fifth of Part D Spending That Year
A new KFF analysis finds that the 10 top-selling prescription drugs under Medicare Part D comprised less than 1 percent of all covered drugs in 2021, but accounted for 22 percent, or $48 billion, of gross Medicare Part D drug spending that year. … more
-
New KFF Analysis Examines Rapidly Evolving Federal Policies For Substance Use Disorder Treatment for the Opioid Epidemic
A new KFF analysis finds that 24 percent more buprenorphine, a medication to treat opioid use disorder, was dispensed in 2022 than in 2019, the year before the pandemic brought a surge of opioid overdose deaths – and a focus on how to expand access and treatment. … more
-
Medicaid Expansion Has Had Beneficial Effects on Some Sexual and Reproductive Health Outcomes
A new KFF review of more than three dozen studies published between April 2021 and June 2023 finds that Medicaid expansion under the Affordable Care Act is associated with beneficial effects on a range of sexual and reproductive health outcomes. … more
-
What Do We Know About People with HIV Who Are Not Engaged in Regular HIV Care?
A new KFF analysis finds that between 2018 and 2020, one-in-five (21%) adults diagnosed with HIV were out of care. … more
Subscribe to KFF Emails
Choose which emails are best for you.
Sign up here